{"id":"dronabinol-capsules","safety":{"commonSideEffects":[{"rate":"10-20","effect":"Dizziness"},{"rate":"10-15","effect":"Drowsiness"},{"rate":"5-10","effect":"Euphoria"},{"rate":"5-10","effect":"Anxiety"},{"rate":"5-10","effect":"Dry mouth"},{"rate":"5-10","effect":"Tachycardia"},{"rate":"3-5","effect":"Abdominal pain"},{"rate":"1-3","effect":"Hallucinations"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Dronabinol (delta-9-tetrahydrocannabinol, THC) binds to and activates cannabinoid receptors, which modulate neurotransmitter release and neuronal signaling. This activation produces appetite stimulation, antiemetic effects, and analgesic properties. The drug crosses the blood-brain barrier and has psychoactive effects due to CB1 receptor activation in the central nervous system.","oneSentence":"Dronabinol is a synthetic cannabinoid that acts as a partial agonist at cannabinoid CB1 and CB2 receptors in the central and peripheral nervous systems.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:10:07.315Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chemotherapy-induced nausea and vomiting (CINV)"},{"name":"Anorexia associated with weight loss in HIV/AIDS patients"},{"name":"Cancer-related cachexia and appetite stimulation"}]},"trialDetails":[{"nctId":"NCT04734080","phase":"PHASE4","title":"Dronabinol in Total Knee Arthroplasty (TKA)","status":"COMPLETED","sponsor":"Hospital for Special Surgery, New York","startDate":"2021-03-09","conditions":"Total Knee Arthroplasty, Opioid Use","enrollment":114},{"nctId":"NCT06454669","phase":"PHASE2","title":"Dronabinol as an Adjunct for Reducing Pain","status":"RECRUITING","sponsor":"Christopher D. Verrico","startDate":"2024-06-15","conditions":"Low Back Pain, Chronic Pain, Back Injuries","enrollment":75},{"nctId":"NCT06834997","phase":"PHASE2","title":"Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital","status":"WITHDRAWN","sponsor":"Baylor College of Medicine","startDate":"2026-04-01","conditions":"Endometriosis, Endometriosis Related Pain, Endometriosis, Pain","enrollment":""},{"nctId":"NCT06533657","phase":"PHASE2","title":"Unique Treatment of Oncology Pain in Advanced Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"ZYUS Life Sciences Inc.","startDate":"2025-06-12","conditions":"Cancer Pain","enrollment":20},{"nctId":"NCT07216690","phase":"PHASE2","title":"Pregnenolone as a Treatment for Cannabis Intoxication","status":"NOT_YET_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2026-04-01","conditions":"Cannabis Intoxication","enrollment":20},{"nctId":"NCT07148206","phase":"PHASE3","title":"Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial","status":"NOT_YET_RECRUITING","sponsor":"Montefiore Medical Center","startDate":"2026-05","conditions":"Opioid Use Disorder","enrollment":40},{"nctId":"NCT07225777","phase":"PHASE2","title":"Sex Differences in Neurobehavioral Response to THC","status":"NOT_YET_RECRUITING","sponsor":"Medical University of South Carolina","startDate":"2026-04-01","conditions":"Cannabis Use Disorder","enrollment":40},{"nctId":"NCT03560934","phase":"EARLY_PHASE1","title":"Tetrahydrocannabinol (THC) and Sleep","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-09-01","conditions":"Sleep, THC, Marijuana","enrollment":18},{"nctId":"NCT06878417","phase":"NA","title":"Cannabinoids for Osteoarthritis Pain Effectiveness Trial","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-01-15","conditions":"Osteoarthritis of Knee, Osteoarthritis Hip","enrollment":100},{"nctId":"NCT07176208","phase":"PHASE1","title":"Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults","status":"RECRUITING","sponsor":"Food and Drug Administration (FDA)","startDate":"2025-12-29","conditions":"Cannabis, Drug Effects, Driving Performance","enrollment":48},{"nctId":"NCT06544291","phase":"PHASE2","title":"Combined THC and CBD for OUD and Chronic Pain","status":"RECRUITING","sponsor":"Yale University","startDate":"2024-10-22","conditions":"Chronic Pain, Opioid Use Disorder","enrollment":147},{"nctId":"NCT01964404","phase":"PHASE1","title":"Cannabis, Schizophrenia and Reward: Self-Medication and Agonist Treatment?","status":"COMPLETED","sponsor":"Dartmouth-Hitchcock Medical Center","startDate":"2014-07","conditions":"Schizophrenia, Dual Diagnosis, Psychotic Disorder","enrollment":263},{"nctId":"NCT06034314","phase":"PHASE1","title":"Oral Dronabinol-HIV","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2023-09-21","conditions":"HIV","enrollment":160},{"nctId":"NCT02069366","phase":"NA","title":"Cannabinoid Control of Fear Extinction Neural Circuits in Post-traumatic Stress Disorder","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2014-11","conditions":"Post-Traumatic Stress Disorder","enrollment":86},{"nctId":"NCT06758596","phase":"EARLY_PHASE1","title":"Research Investigating Drug Effects-2 (RiDE-2)","status":"NOT_YET_RECRUITING","sponsor":"University of Illinois at Chicago","startDate":"2026-07-15","conditions":"Cannabis Use, Substance Use Disorder (SUD), Healthy","enrollment":144},{"nctId":"NCT04992624","phase":"PHASE2","title":"Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee","status":"RECRUITING","sponsor":"Steven E Harte, PhD","startDate":"2022-02-22","conditions":"Osteoarthritis, Knee, Osteoarthritis of the Knee","enrollment":200},{"nctId":"NCT03008005","phase":"PHASE4","title":"Effects of Delta-9 Tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R61 Study","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2017-06-01","conditions":"PostTraumatic Stress Disorder","enrollment":46},{"nctId":"NCT06471647","phase":"EARLY_PHASE1","title":"Effects of Drugs on Stress Memories","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2024-07-01","conditions":"Delta-9-tetrahydrocannabinol (THC), Stress","enrollment":36},{"nctId":"NCT05269628","phase":"PHASE2","title":"Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype","status":"RECRUITING","sponsor":"Tiffany J. Braley, MD, MS","startDate":"2022-03-25","conditions":"Multiple Sclerosis, Sleep, Pain","enrollment":166},{"nctId":"NCT06967051","phase":"NA","title":"The Efficacy of a Smart Phone-based Test on Measuring Pupillary Light Reflex Alterations Following Cannabis Use Healthy in Adults","status":"RECRUITING","sponsor":"Sobereye Inc.","startDate":"2025-05-22","conditions":"Cannabis Intoxication, Drug Effects","enrollment":20},{"nctId":"NCT04080427","phase":"PHASE1","title":"Effects of Delta9-tetrahydrocannabinol (THC) on Retention of Memory for Fear Extinction Learning in PTSD: R33 Study","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2021-04-15","conditions":"Posttraumatic Stress Disorder","enrollment":102},{"nctId":"NCT02811510","phase":"PHASE1","title":"Gender Related Differences in the Acute Effects of Delta-9-Tetrahydrocannabinol in Healthy Humans: Sub-Study I","status":"RECRUITING","sponsor":"Yale University","startDate":"2016-06","conditions":"Cannabis","enrollment":40},{"nctId":"NCT04512365","phase":"EARLY_PHASE1","title":"Reward and Drug Effects on Mood and Brain Response","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2021-03-16","conditions":"Cannabis Use, Healthy","enrollment":141},{"nctId":"NCT06378957","phase":"PHASE1","title":"Behavioral Pharmacology of Orally Administered THC and D-limonene","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2025-02-14","conditions":"Subjective Drug Effects, THC, D-limonene","enrollment":65},{"nctId":"NCT05126888","phase":"PHASE2","title":"SCI-110 in the Treatment of Tourette Syndrome","status":"NOT_YET_RECRUITING","sponsor":"Neurothera Labs Inc.","startDate":"2025-08","conditions":"Tourette Syndrome","enrollment":164},{"nctId":"NCT02792257","phase":"PHASE2","title":"Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2017-03-01","conditions":"Alzheimer's Disease","enrollment":84},{"nctId":"NCT06146101","phase":"PHASE2, PHASE3","title":"RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA","status":"ACTIVE_NOT_RECRUITING","sponsor":"Incannex Healthcare Ltd","startDate":"2024-05-02","conditions":"Obstructive Sleep Apnea","enrollment":560},{"nctId":"NCT02710331","phase":"PHASE1","title":"Ethanol and Cannabinoid Effects on Simulated Driving and Related Cognition: Substudy III","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2016-03","conditions":"Cannabis, Alcohol Effect, Driving Under the Influence of Alcohol and Other Drugs","enrollment":40},{"nctId":"NCT06473701","phase":"PHASE3","title":"Reducing Breathlessness With Dronabinol in COPD Patients","status":"RECRUITING","sponsor":"Vejle Hospital","startDate":"2025-02-26","conditions":"COPD, Breathlessness, Cannabis","enrollment":30},{"nctId":"NCT02492074","phase":"PHASE1","title":"Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids - a PET Study","status":"WITHDRAWN","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2024-12","conditions":"Healthy Volunteers, Modeling Psychosis","enrollment":""},{"nctId":"NCT04989413","phase":"PHASE2, PHASE3","title":"Cannabidiol 133mg + Cannabigerol 66mg + Tetrahydrocannabinol 4mg Vs Placebo As Adjuvant Treatment in Chronic Migraine -","status":"TERMINATED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2022-10-18","conditions":"Chronic Migraine, Headache, Overuse Headache Medication","enrollment":110},{"nctId":"NCT05514899","phase":"PHASE2","title":"Effects of Cannabidiol and Tetrahydrocannabinol on Microbiome and Neuroinflammation in HIV","status":"RECRUITING","sponsor":"University of California, San Diego","startDate":"2023-09-01","conditions":"HIV, Cannabis, THC","enrollment":90},{"nctId":"NCT05857384","phase":"PHASE1","title":"Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs","status":"COMPLETED","sponsor":"Incannex Healthcare Ltd","startDate":"2023-09-08","conditions":"Obstructive Sleep Apnea","enrollment":125},{"nctId":"NCT03337503","phase":"PHASE2","title":"Safety and Efficacy of Medical Cannabis Oil in the Treatment of Patients with Chronic Pain","status":"TERMINATED","sponsor":"Santé Cannabis","startDate":"2018-01-29","conditions":"Chronic Pain","enrollment":161},{"nctId":"NCT03804840","phase":"EARLY_PHASE1","title":"Developing a Mobile Method to Measure THC-induced Impairment","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2017-03-01","conditions":"Measuring THC-induced Cognitive Impairment Using a Mobile Application","enrollment":72},{"nctId":"NCT02310347","phase":"NA","title":"Influence of a Medicinal Cannabinoid Agonist on Responses to Food Images and Food Intake","status":"ACTIVE_NOT_RECRUITING","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2014-12","conditions":"Appetite Regulation","enrollment":18},{"nctId":"NCT05612711","phase":"PHASE2","title":"Dronabinol for Agitation in Dementia Crossover Trial","status":"WITHDRAWN","sponsor":"Ralph H. Johnson VA Medical Center","startDate":"2023-11","conditions":"Dementia Moderate, Dementia Severe, Agitation,Psychomotor","enrollment":""},{"nctId":"NCT03809546","phase":"EARLY_PHASE1","title":"Individual Differences in Drug Response","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2018-11-06","conditions":"Differential Female Response to Δ9-tetrahydrocannabinol (THC)","enrollment":60},{"nctId":"NCT03944954","phase":"EARLY_PHASE1","title":"Neural Mechanisms of Cannabinoid-impaired Decision-Making in Emerging Adults","status":"COMPLETED","sponsor":"Michael J. Wesley, PhD","startDate":"2017-07-15","conditions":"Neurosciences, Substance-Related Disorders, Behavior Problem","enrollment":66},{"nctId":"NCT04099355","phase":"EARLY_PHASE1","title":"Investigating the Effect of Dronabinol on Post-surgical Pain","status":"WITHDRAWN","sponsor":"New York State Psychiatric Institute","startDate":"2025-09-01","conditions":"Knee Replacement, Arthropathy of Knee","enrollment":""},{"nctId":"NCT04294966","phase":"EARLY_PHASE1","title":"Age-Related Effects of THC","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2020-03-10","conditions":"Tolerance, Adolescent Behavior, THC","enrollment":24},{"nctId":"NCT04970342","phase":"PHASE1","title":"Validation of the Drug Impaired Driving Scenario (DIDS) on the CRCDS-miniSim","status":"COMPLETED","sponsor":"Timothy L. Brown","startDate":"2021-07-16","conditions":"Driving Behavior, Driving Under the Influence","enrollment":13},{"nctId":"NCT01323569","phase":"PHASE1","title":"Abuse Potential of Sativex","status":"COMPLETED","sponsor":"Jazz Pharmaceuticals","startDate":"2008-02","conditions":"Evaluation of Abuse Potential of Sativex","enrollment":58},{"nctId":"NCT03805750","phase":"PHASE1, PHASE2","title":"Trial of Cannabis for Essential Tremor","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2019-01-22","conditions":"Essential Tremor","enrollment":7},{"nctId":"NCT03550352","phase":"PHASE2","title":"Cannabinoids in PLWHIV on Effective ART","status":"TERMINATED","sponsor":"McGill University Health Centre/Research Institute of the McGill University Health Centre","startDate":"2021-08-20","conditions":"HIV Infections","enrollment":10},{"nctId":"NCT04808531","phase":"PHASE3","title":"NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers","status":"UNKNOWN","sponsor":"Medlab Clinical","startDate":"2023-11","conditions":"Cancer Related Pain","enrollment":360},{"nctId":"NCT02811939","phase":"PHASE1","title":"Testing the Interactive Effects of Delta-9-Tetrahydrocannabinol and Pregnenolone: Sub-Study I","status":"COMPLETED","sponsor":"Yale University","startDate":"2016-04-07","conditions":"Healthy","enrollment":13},{"nctId":"NCT05239390","phase":"PHASE2","title":"SCI-110 for Alzheimer Disease and Agitation","status":"UNKNOWN","sponsor":"The Israeli Medical Center for Alzheimer's","startDate":"2021-12-29","conditions":"Alzheimer Disease","enrollment":20},{"nctId":"NCT05235503","phase":"PHASE4","title":"Influence of Δ9-tetrahydrocannabinol (THC) on Oxycodone Induced Ventilatory Depression in Healthy Volunteers","status":"UNKNOWN","sponsor":"Leiden University Medical Center","startDate":"2021-12-09","conditions":"Respiratory Depression, Cannabis Use, Opioid Use","enrollment":20},{"nctId":"NCT04958876","phase":"PHASE1","title":"Study to Evaluate the Safety of SP-104","status":"COMPLETED","sponsor":"Scilex Pharmaceuticals, Inc.","startDate":"2021-10-04","conditions":"Healthy Volunteers","enrollment":52},{"nctId":"NCT05108220","phase":"","title":"Evaluation of Effects of CBD Products on Anxiety Among U.S. Women","status":"COMPLETED","sponsor":"Radicle Science","startDate":"2020-10-15","conditions":"Anxiety, Generalized Anxiety Disorder","enrollment":1350},{"nctId":"NCT04346407","phase":"PHASE4","title":"Dronabinol for Post-operative Pain After Lumbar Fusion","status":"UNKNOWN","sponsor":"Jeffrey L Gum MD","startDate":"2020-09-01","conditions":"Post-operative Pain","enrollment":90},{"nctId":"NCT03978156","phase":"PHASE1","title":"Dronabinol for Pain and Inflammation in Adults Living With Sickle Cell Disease","status":"TERMINATED","sponsor":"Yale University","startDate":"2019-07-26","conditions":"Sickle Cell Disease","enrollment":6},{"nctId":"NCT03808935","phase":"PHASE3","title":"Cannabis Extract in Refractory Epilepsy Study","status":"TERMINATED","sponsor":"The Epilepsy Research Program of the Ontario Brain Institute","startDate":"2019-01-10","conditions":"Drug Resistant Epilepsy","enrollment":17},{"nctId":"NCT04316598","phase":"PHASE1","title":"Cannabis Effects on Electroencephalography","status":"TERMINATED","sponsor":"Parc de Salut Mar","startDate":"2020-03-03","conditions":"Healthy Volunteers","enrollment":16},{"nctId":"NCT03604341","phase":"PHASE4","title":"Cannabinoids for Pain Control During Medical Abortion","status":"COMPLETED","sponsor":"Oregon Health and Science University","startDate":"2018-11-01","conditions":"Medical Abortion, Pain","enrollment":72},{"nctId":"NCT03164512","phase":"PHASE1","title":"The Pharmacokinetics and Pharmacodynamics of Oral and Vaporized Cannabidiol","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2018-06-01","conditions":"Cannabidiol Pharmacokinetics","enrollment":19},{"nctId":"NCT00480441","phase":"PHASE2","title":"Effectiveness Study of Dronabinol and BRENDA for the Treatment of Cannabis Withdrawal","status":"COMPLETED","sponsor":"University of Pennsylvania","startDate":"2006-08","conditions":"Marijuana Dependence","enrollment":61},{"nctId":"NCT02608931","phase":"PHASE2","title":"The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia","status":"WITHDRAWN","sponsor":"NYU Langone Health","startDate":"2015-11","conditions":"Nausea, Vomiting, Familial Dysautonomia","enrollment":""},{"nctId":"NCT03744091","phase":"PHASE1","title":"Evaluation of the Pharmacokinetics of Prana P1 Capsules","status":"UNKNOWN","sponsor":"The University of The West Indies","startDate":"2018-07-16","conditions":"Healthy","enrollment":13},{"nctId":"NCT03471585","phase":"EARLY_PHASE1","title":"Effects of THC on Emotional Memory Retrieval","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2017-02-15","conditions":"Healthy","enrollment":24},{"nctId":"NCT03907163","phase":"NA","title":"The Effect of Tetrahydrocannabinol on Ocular Hemodynamics in Healthy Subjects","status":"COMPLETED","sponsor":"Medical University of Vienna","startDate":"2018-07-02","conditions":"Retinal Blood Flow","enrollment":24},{"nctId":"NCT03635593","phase":"PHASE2","title":"Cannabis Oil for Chronic Non-Cancer Pain Treatment","status":"UNKNOWN","sponsor":"Hamilton Health Sciences Corporation","startDate":"2019-01-01","conditions":"Chronic Non-cancer Pain","enrollment":309},{"nctId":"NCT00743145","phase":"PHASE2","title":"Effects of Low-dose Naltrexone in Combination With a Range of Smoked Marijuana","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-05","conditions":"Marijuana Smoking","enrollment":23},{"nctId":"NCT01598896","phase":"PHASE2, PHASE3","title":"Combination of Dronabinol and Clonidine for Cannabis Dependence in Patients With Schizophrenia","status":"TERMINATED","sponsor":"Mclean Hospital","startDate":"2012-05","conditions":"Cannabis Dependence, Marijuana Dependence","enrollment":12},{"nctId":"NCT03651726","phase":"PHASE2","title":"A Study to Examine the Efficacy of a Therapeutic THX-110 for Tourette Syndrome","status":"UNKNOWN","sponsor":"Neurothera Labs Inc.","startDate":"2018-08","conditions":"Tourette Syndrome","enrollment":60},{"nctId":"NCT03398083","phase":"PHASE1","title":"Evaluation of the Effects of Cannabidiol (CBD) Compared to Delta-9-Tetrahydrocannabinol (THC) and Alprazolam","status":"COMPLETED","sponsor":"National Institute on Drug Abuse (NIDA)","startDate":"2017-12-04","conditions":"Cannabis Use Disorder","enrollment":42},{"nctId":"NCT00403117","phase":"PHASE2","title":"Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2006-12","conditions":"Marijuana Use","enrollment":49},{"nctId":"NCT00743119","phase":"PHASE2","title":"Comparison of the Analgesic Effects of Dronabinol and Smoked Marijuana in Daily Marijuana Smokers","status":"COMPLETED","sponsor":"New York State Psychiatric Institute","startDate":"2008-06","conditions":"Pain Threshold, Mood","enrollment":34},{"nctId":"NCT03005119","phase":"PHASE2","title":"Evaluation of the Safety, Tolerability, and Efficacy of Orally Administered PTL201 in MS Patients With Spasticity-related Symptoms","status":"UNKNOWN","sponsor":"PhytoTech Therapeutics, Ltd.","startDate":"2018-03-01","conditions":"Multiple Sclerosis","enrollment":70},{"nctId":"NCT03098940","phase":"PHASE1","title":"A Bioavailability Study on Dronabinol","status":"UNKNOWN","sponsor":"Axim Biotechnologies","startDate":"2018-01","conditions":"THC","enrollment":50},{"nctId":"NCT02485158","phase":"NA","title":"Individual Differences in the Response to Drugs","status":"COMPLETED","sponsor":"University of Chicago","startDate":"2013-07","conditions":"Healthy","enrollment":28},{"nctId":"NCT00943930","phase":"","title":"Marijuana Drug Discrimination and Self-Administration","status":"COMPLETED","sponsor":"Wayne State University","startDate":"2009-04","conditions":"Marijuana Abuse","enrollment":29},{"nctId":"NCT01893424","phase":"PHASE1","title":"Bioequivalence Assessment of Oral Administration Vs. Oral Spray of a Cannabinoids (Tetrahydrocannabinol and Cannabidiol)","status":"COMPLETED","sponsor":"Hadassah Medical Organization","startDate":"2013-08","conditions":"Pain","enrollment":12},{"nctId":"NCT02604992","phase":"NA","title":"Comparative Bioavailability of Dronabinol Oral Solution in Healthy Volunteers","status":"COMPLETED","sponsor":"INSYS Therapeutics Inc","startDate":"2015-11","conditions":"Healthy","enrollment":54},{"nctId":"NCT01832766","phase":"PHASE1, PHASE2","title":"The Effects of Cannabis Use in People With Schizophrenia on Clinical, Neuropsychological and Physiological Phenotypes","status":"TERMINATED","sponsor":"University of Colorado, Denver","startDate":"2005-06","conditions":"Schizophrenia","enrollment":13},{"nctId":"NCT02472847","phase":"PHASE4","title":"Cannabinoid Control of Fear Extinction Neural Circuits in Humans","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2012-05","conditions":"Healthy Participants","enrollment":85},{"nctId":"NCT02487381","phase":"PHASE1","title":"Gene-Environment-Interaction: Influence of the COMT Genotype on the Effects of Different Cannabinoids","status":"COMPLETED","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2015-04","conditions":"Healthy, Modeling Psychosis","enrollment":60},{"nctId":"NCT00552604","phase":"PHASE3","title":"MUltiple Sclerosis and Extract of Cannabis (MUSEC) Study","status":"TERMINATED","sponsor":"Institut fur Klinische Forschung, Germany","startDate":"2006-06","conditions":"Muscle Spasticity","enrollment":279},{"nctId":"NCT02291562","phase":"NA","title":"Effects of THC and CBD on Human Episodic Memory Function","status":"COMPLETED","sponsor":"Central Institute of Mental Health, Mannheim","startDate":"2014-07","conditions":"Healthy Volunteers","enrollment":20},{"nctId":"NCT02094599","phase":"PHASE1","title":"A Study of the Abuse Potential of Dronabinol in Recreational Cannabinoid Users","status":"COMPLETED","sponsor":"INSYS Therapeutics Inc","startDate":"2014-02","conditions":"Drug Abuse, Medication","enrollment":43},{"nctId":"NCT00362089","phase":"NA","title":"Fatty Acids During Pregnancy and Lactation and Body Fat Mass in Newborns","status":"COMPLETED","sponsor":"Technical University of Munich","startDate":"2006-06","conditions":"Overweight, Obesity","enrollment":208},{"nctId":"NCT01448772","phase":"PHASE1","title":"Comparative Bioavailability of Dronabinol Oral Solution Versus Branded Capsule 5 mg Under Fasting Conditions","status":"COMPLETED","sponsor":"INSYS Therapeutics Inc","startDate":"2011-10","conditions":"Bioavailability","enrollment":88},{"nctId":"NCT01380457","phase":"PHASE1","title":"Bioavailability Study of Dronabinol Capsules 10 mg Under Fasting Conditions","status":"COMPLETED","sponsor":"Par Pharmaceutical, Inc.","startDate":"2006-01","conditions":"To Determine Bioequivalence Under Fasting Conditions","enrollment":69}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":8,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Marinol","delta-9-tetrahydrocannabinol","Syndros"],"phase":"phase_3","status":"active","brandName":"Dronabinol Capsules","genericName":"Dronabinol Capsules","companyName":"Montefiore Medical Center","companyId":"montefiore-medical-center","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Dronabinol is a synthetic cannabinoid that acts as a partial agonist at cannabinoid CB1 and CB2 receptors in the central and peripheral nervous systems. Used for Chemotherapy-induced nausea and vomiting (CINV), Anorexia associated with weight loss in HIV/AIDS patients, Cancer-related cachexia and appetite stimulation.","enrichmentLevel":3,"visitCount":0,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2016-07-01T00:00:00.000Z","mah":"WELLHOUSE PHARMA","brand_name_local":"SYNDROS","application_number":"NDA205525"}],"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}